What happens when psychedelic therapy gets approved? Kimberly Chew explains FDA rules, costs, insurance, safety and access.
Podcast
- Jill Sitnick
- No Comments
Paije West explores the differences between iboga and ibogaine, what really happens in ceremony, why medical screening matters, and the importance of honoring Bwiti traditions.
- Jill Sitnick
- 2 Comments
Discover how AI is transforming psychedelic integration by helping practitioners provide personalized support between sessions without replacing care.
- Jill Sitnick
- No Comments
John Gilchrist of Therapsil explains how psilocybin therapy is helping end-of-life patients ease anxiety, find meaning, and embrace acceptance.
- Jill Sitnick
- No Comments
Christian Rasmussen explains what people get wrong about Amanita muscaria, its reported effects, and key safety considerations.
- Jill Sitnick
- No Comments
In this episode of the Psychedelic Scene Podcast, Jill Sitnick sits down with Rhonda DeSantis, founder of Psylutions and one of Colorado’s first licensed psilocybin cultivators, manufacturers, and distributors.
- Jill Sitnick
- No Comments
Considering psychedelic work? Learn key safety guidelines, red flags to watch for, and how preparation and integration support lasting change.
- Jill Sitnick
- No Comments
Explore iboga and ibogaine through their African roots, safety protocols, addiction research, and the deeply introspective experiences they can inspire.
- Jill Sitnick
- No Comments
Podcast guest Jonathan Mozenter explains why psychedelic breakthroughs alone rarely create lasting change—and how preparation, integration, and updating old mental patterns lead to real transformation.